# Can a GLP-1 Cause Low Blood Sugar? How Insulin Changes the Risk | Buy This GLP

Learn how insulin and sulfonylureas affect low blood sugar risk with GLP-1 drugs, and what avexitide trials found after gastric bypass.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/can-a-glp1-cause-low-blood-sugar
Updated: 2026-11-15
Published: 2026-09-17

[← Research](https://buythisglp.com/research)

Evidence

# Can a GLP-1 Cause Low Blood Sugar? How Insulin Changes the Risk

Taking a GLP-1 with insulin can raise the risk of low blood sugar. Trials of post-bariatric hypoglycemia address a different cause.

Editorial profile: [Carla Medina](https://buythisglp.com/authors/carla-medina)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20269 min readUpdated November 2026

The same receptor, drugged in opposite directions · Semaglutide, tirzepatide · switch the receptor ON · less appetite, less weight · Avexitide · switches it OFF · fewer hypoglycemic events · Reductions against each participant’s own two-week run-in · severe events · −67.5% · time below 54 mg/dL · −64% · daytime level 2 events · −59% · 16 participants. No placebo arm — the comparison is with themselves, before.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   The risk of low blood sugar increases when semaglutide is taken with insulin or a sulfonylurea.
-   A 26-week trial in adults with type 1 diabetes recorded two severe lows in each group. That small study cannot rule out differences in risk.
-   Post-bariatric hypoglycemia has its own evidence base. A trial of avexitide, an investigational GLP-1 receptor blocker, studied participants with lows after gastric bypass.

Semaglutide stimulates insulin release in response to glucose. Its prescribing information warns that people taking insulin or a sulfonylurea alongside it may be more likely to develop hypoglycemia [\[4\]](https://buythisglp.com/research/can-a-glp1-cause-low-blood-sugar#ref-4). Our guide to [how a GLP-1 fits with your existing medicines](https://buythisglp.com/research/does-a-glp1-replace-your-other-medications) helps you prepare questions for your visit. If you take either medicine, discuss the combination with the clinician who manages your diabetes.

## What the insulin trials measured

The [semaglutide trial with automated insulin delivery](https://buythisglp.com/research/semaglutide-type-1-diabetes-trial) studied adults with type 1 diabetes in a separate setting. The results below describe different medicines and study populations.

In [REIMAGINE 3](https://buythisglp.com/research/adding-a-combination-to-insulin), adding cagrilintide-semaglutide to basal insulin lowered HbA1c more than placebo in adults with type 2 diabetes. The study reported no severe hypoglycemia [\[3\]](https://buythisglp.com/research/can-a-glp1-cause-low-blood-sugar#ref-3). Its group averages cannot determine whether an individual needs a change in insulin dose.

A separate 26-week trial randomized 72 adults with type 1 diabetes and obesity who used automated insulin delivery. The study recorded two severe lows in each group and no reported diabetic ketoacidosis [\[2\]](https://buythisglp.com/research/can-a-glp1-cause-low-blood-sugar#ref-2). The trial was too small to establish how frequently rare harms occur.

## Low blood sugar after bariatric surgery

Post-bariatric hypoglycemia can occur after meals, in part because the gut releases more GLP-1 and stimulates insulin release. The research on [GLP-1 treatment around bariatric surgery](https://buythisglp.com/research/do-you-take-a-glp1-before-or-after-bariatric-surgery) addresses weight management, a separate question from treating recurrent lows [\[1\]](https://buythisglp.com/research/can-a-glp1-cause-low-blood-sugar#ref-1).

## What the avexitide studies found

In a phase 2b study with 16 completers, daytime level 2 events measured by continuous glucose monitoring fell by 47.7% and 59.0% during two avexitide regimens. The researchers compared each treatment period with the same participants’ run-in period [\[1\]](https://buythisglp.com/research/can-a-glp1-cause-low-blood-sugar#ref-1).

The phase 2b and phase 3 studies measured different outcomes

In a separate placebo-controlled phase 3 trial with 78 participants after gastric bypass, the sponsor reported a 55% lower combined rate of level 2 and level 3 hypoglycemia through week 16 with avexitide [\[5\]](https://buythisglp.com/research/can-a-glp1-cause-low-blood-sugar#ref-5). That figure comes from a sponsor report and measures a different outcome from the phase 2b daytime result.

## Frequently asked

What raises the risk of hypoglycemia with semaglutide?

The prescribing information warns that using semaglutide alongside insulin or a sulfonylurea can raise the risk. Ask your prescriber whether your medicines need a review.

Did the semaglutide trial in adults with type 1 diabetes find more severe lows?

The 26-week trial recorded two severe events in each group. With 72 people randomized, it could not rule out differences in uncommon events.

Does avexitide treat post-bariatric hypoglycemia?

Avexitide is investigational. In phase 3, the sponsor reported fewer combined level 2 and level 3 events than with placebo in participants who had gastric bypass.

## Sources

1.  \[1\] Craig C, et al. (2026). Efficacy and safety of avexitide for treatment of hypoglycemia following bariatric and other upper gastrointestinal surgeries: a phase 2b study Metabolism: Clinical and Experimental. [PMID 42744082](https://pubmed.ncbi.nlm.nih.gov/42744082/)
2.  \[2\] Shah VN, et al. (2025). Semaglutide in Adults with Type 1 Diabetes and Obesity NEJM Evidence. [PMID 40550013](https://pubmed.ncbi.nlm.nih.gov/40550013/)
3.  \[3\] Rosenstock J, Billings LK, Gajria R, Giorgino F, Johansen NB, Klein KR (2026). Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study The Lancet. [PMID 42251856](https://pubmed.ncbi.nlm.nih.gov/42251856/)
4.  \[4\] Novo Nordisk (2026). Ozempic prescribing information DailyMed. [Source](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42bdd912-2393-44c4-b7e0-47672ca28991)
5.  \[5\] Amylyx Pharmaceuticals (2026). LUCIDITY phase 3 topline results SEC Form 8-K, Exhibit 99.1. [Source](https://www.sec.gov/Archives/edgar/data/1658551/000119312526354716/d180533dex991.htm)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
